共 131 条
[11]
Lipshultz SE(2013)Risk of ischemic heart disease in women after radiotherapy for breast cancer N Engl J Med 368 987-1283
[12]
Colan SD(2011)Adjuvant trastuzumab in HER2-positive breast cancer N Engl J Med 365 1273-1684
[13]
Gelber RD(2005)Trastuzumab plus adjuvant chemotherapy for operable HER2-positive breast cancer N Engl J Med 353 1673-3865
[14]
Perez-Atayde AR(2007)Trastuzumab-associated cardiac adverse effects in the herceptin adjuvant trial J Clin Oncol 25 3859-2512
[15]
Sallan SE(2012)Incidence of heart failure or cardiomyopathy after adjuvant trastuzumab therapy for breast cancer J Am Coll Cardiol 60 2504-2142
[16]
Sanders SP(2013)Cardiac toxicity in cancer survivors Cancer 119 2131-vii166
[17]
Mulrooney DA(2012)Cardiovascular toxicity induced by chemotherapy, targeted agents and radiotherapy: ESMO clinical practice guidelines Annals of oncology : official journal of the European Society for Medical Oncology 23 vii155-e479
[18]
Yeazel MW(2009)Focused update incorporated into the ACC/AHA 2005 guidelines for the diagnosis and management of heart failure in adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines: developed in collaboration with the International Society for Heart and Lung Transplantation Circulation 119 e391-220
[19]
Kawashima T(2010)Anthracycline-induced cardiomyopathy: clinical relevance and response to pharmacologic therapy J Am Coll Cardiol 55 213-1949
[20]
Galper SL(2015)Anthracycline cardiotoxicity: a new paradigm for an old classic Circulation 131 1946-828